Imricor Secures Second U.S. Customer for NorthStar System
Key points
- Children's Medical Center Dallas becomes second U.S. customer
- Installation in existing Philips iMR lab with no construction required
- NorthStar to enable 100% radiation-free cardiac catheterization procedures
Full summary
Imricor Medical Systems, Inc. (ASX: IMR) has announced that Children's Medical Center Dallas will adopt its NorthStar interventional magnetic resonance (iMR) mapping and guidance system. This marks the second U.S. hospital to purchase the NorthStar system, following Rady Children's Hospital-San Diego. Children's Medical Center Dallas, a leading pediatric healthcare provider, will utilize the NorthStar system in its existing Philips iMR lab, eliminating the need for lab construction. The hospital plans to launch a NorthStar-guided iMR cardiac catheterization program, offering 100% radiation-free procedures for children with congenital heart disease. This adoption validates the commercial momentum behind Imricor's U.S. launch and the newly established Imricor Cardiovascular vertical.
Summary generated by a large language model. Please interpret with care.